HealthDay - FRIDAY, Nov. 18 (HealthDay News) -- The U.S. Food and Drug Administration announced Friday that it is revoking Avastin's approval to treat breast cancer because the drug has not been shown to be safe and effective for that use.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.